IBT welcomes new Business Analyst

September 2, 2016

IBT welcomes Crescent Yingyue Liao as Business Analyst.

Crescent holds a Bachelor’s degree in Biochemistry and a Master’s degree in Bioentrepreneurship.

Latest press releases

2023-11-10 08:30 Infant Bacterial Therapeutics AB (publ), Interim report January 1-September 30, 2023 Regulatory

2023-10-24 10:50 Infant Bacterial Therapeutics AB (publ) announces the appointment of the Nomination Committee for the Annual General Meeting 2024 Regulatory

2023-08-25 08:30 Infant Bacterial Therapeutics AB (publ) Interim report January 1 - June 30, 2023

2023-07-31 10:00 New number of shares and votes in IBT Regulatory

2023-07-04 08:30 IBT announces outcome of its rights issue Regulatory

News